Elafibranor: A New Era in the Treatment of Primary Biliary Cholangitis

At Star Hope Liver Center, we are committed to delivering cutting-edge care and the latest
advancements in liver health to our patients. We're excited to share groundbreaking news in the
field of hepatology: on June 12, 2024, the FDA approved Elafibranor for the treatment of
Primary Biliary Cholangitis (PBC)—a chronic and progressive autoimmune liver disease.
Understanding Primary Biliary Cholangitis (PBC)
PBC is a rare condition where the immune system attacks the small bile ducts in the liver. Over
time, this leads to bile buildup, liver inflammation, fibrosis, and, if untreated, biliary
cirrhosis—a form of liver failure. Symptoms can range from fatigue and itching to more
advanced signs such as jaundice and liver dysfunction.
At Star Hope, we understand the physical and emotional toll of this disease, and we strive to
bring patients not just hope—but results.
What Makes Elafibranor a Game-Changer?
Elafibranor is a dual PPAR-α/δ agonist, meaning it targets key receptors involved in
inflammation and lipid metabolism. Its mechanism helps regulate bile acid production, reduce
inflammation, and slow or even reverse liver damage—an ideal therapeutic approach for
PBC.
Here's what sets it apart:
● ✔ Clinically Proven: Elafibranor has demonstrated strong results in clinical trials,
particularly in reducing alkaline phosphatase (ALP), a primary marker of disease
activity in PBC.
● ✔ Option for Those with Limited Alternatives: It offers a new path forward for
patients who have not responded adequately to Ursodeoxycholic Acid (UDCA) or
are unable to tolerate it.
● ✔ Convenient Oral Therapy: Taken by mouth, Elafibranor is a convenient,
well-tolerated treatment suitable for long-term management.
What This Means for Our Patients
At Star Hope Liver Center, we believe that access to the latest therapies can change lives.
Elafibranor brings new promise to PBC patients who have had few options. Its approvalexpands our ability to tailor treatment plans that address both the biological drivers of disease
and the quality of life our patients deserve.
By integrating Elafibranor into our care strategies, we aim to:
●Improve liver function over time
●Reduce uncomfortable symptoms such as fatigue and itching
●Delay or prevent progression to cirrhosis and its complications
Partnering With You for a Healthier Future
As leaders in liver disease care, Star Hope Liver Center is proud to be at the forefront of new
treatments like Elafibranor. We are here to guide our patients through every step—offering
personalized care, clinical expertise, and compassionate support.
If you or a loved one is living with Primary Biliary Cholangitis, we encourage you to schedule a
consultation with our hepatology team. Learn more at www.starhopeliver.com or call us today
to explore your treatment options.
Star Hope Liver Center
Dedicated to hope, healing, and liver health.

